GlassScriptPhysician profile
Robert Michael Brody
NPI 1164785523
$2,790.54
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $116 · 2020: $121 · 2022: $325 · 2023: $1,660 · 2024: $570.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,210 · Travel and Lodging: $1,020.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,209.56 |
| Travel and Lodging | $1,019.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,406.54 | 2023 | Na, Sonopet Iq, Patient-Fitted Tmj Reconstructive Prosthesis System |
| Baxter Healthcare | $539.98 | 2019-2024 | Tisseel |
| Integra Lifesciences Corporation | $151.16 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Tactile Systems Technology INC | $150.19 | 2023 | Flexitouch Plus, Entre Plus |
| Axogen | $129.60 | 2024 | Axoguard Ha+ Nerve Protector, Axoguard Nerve Connector, Avance Nerve Graft |
| Allergan, INC. | $120.78 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $111.82 | 2024 | Dupixent |
| Atos Medical INC | $84.80 | 2023 | Provox Life Home Hme |
| Acera Surgical, INC. | $57.48 | 2022 | |
| Depuy Synthes Sales INC. | $20.09 | 2019 | |
| Medical Device Business Services, INC. | $18.10 | 2023 | Matrixcombo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Brody listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.